Literature DB >> 33850275

The challenges and opportunities of traditional Chinese medicines against COVID-19: a way out from a network perspective.

Hua-Li Zuo1,2,3, Yang-Chi-Dung Lin1,2, Hsi-Yuan Huang1,2, Xu Wang4, Yun Tang1,2, Yuan-Jia Hu5, Xiang-Jun Kong5, Qian-Jun Chen6,7, Yu-Zhu Zhang6,7, Hsiao-Chin Hong1,2, Jing Li1,2, Si-Yao Hu1,2, Hsien-Da Huang8,9.   

Abstract

Entities:  

Year:  2021        PMID： 33850275     DOI： 10.1038/s41401-021-00645-0

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN： 1671-4083            Impact factor:   6.150


× No keyword cloud information.
  1 in total
  1 in total
  4 in total

1.  Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy.

Authors:  Yan-Ni Wang; Hao-Yu Feng; Xin Nie; Ya-Mei Zhang; Liang Zou; Xia Li; Xiao-Yong Yu; Ying-Yong Zhao
Journal:  Front Pharmacol       Date:  2022-05-26       Impact factor: 5.988

Review 2.  Network Pharmacology Approach for Medicinal Plants: Review and Assessment.

Authors:  Fatima Noor; Muhammad Tahir Ul Qamar; Usman Ali Ashfaq; Aqel Albutti; Ameen S S Alwashmi; Mohammad Abdullah Aljasir
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-04

3.  An anti-inflammatory and anti-fibrotic proprietary Chinese medicine nasal spray designated as Allergic Rhinitis Nose Drops (ARND) with potential to prevent SARS-CoV-2 coronavirus infection by targeting RBD (Delta)- angiotensin converting enzyme 2 (ACE2) binding.

Authors:  Ka Man Yip; Kwan Ming Lee; Tzi Bun Ng; Shujun Xu; Ken Kin Lam Yung; Shaogang Qu; Allen Ka Loon Cheung; Stephen Cho Wing Sze
Journal:  Chin Med       Date:  2022-07-27       Impact factor: 4.546

4.  Development of a Multi-Target Strategy for the Treatment of Vitiligo via Machine Learning and Network Analysis Methods.

Authors:  Jiye Wang; Lin Luo; Qiong Ding; Zengrui Wu; Yayuan Peng; Jie Li; Xiaoqin Wang; Weihua Li; Guixia Liu; Bo Zhang; Yun Tang
Journal:  Front Pharmacol       Date:  2021-09-15       Impact factor: 5.810
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.